In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting:
Name: Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH).
Time and Date: 9 a.m.—3 p.m., March 7, 2002.
Place: Washington Court Hotel on Capitol Hill, 525 New Jersey Avenue, NW., Washington, DC 20001, telephone 202/628-2100, fax 202/879-7938.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people.
Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors shall provide guidance to the Director, National Institute for Occupational Safety and Health, on research and preventions programs. Specifically, the Board shall provide guidance on the Institute's research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board shall evaluate the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results.
Matters to be Discussed: Agenda items include a report from the Acting Director of NIOSH; Update on NIOSH/NCI Diesel Exposure Study; Final Report from the BSC Beryllium Subcommittee; Workplace Violence Prevention Research and Planning; Update on the National Personal Protective Technologies Laboratory.
Agenda items are subject to change as priorities dictate.Start Further Info
FOR MORE INFORMATION CONTACT:
Roger Rosa, Executive Secretary, BSC, NIOSH, CDC, 200 Independence Avenue, SW., Room 715H, Washington, DC 20201, telephone: 202/205-7856, fax: 202/260-4464.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: February 13, 2002.
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 02-4023 Filed 2-19-02; 8:45 am]
BILLING CODE 4163-19-P